NovaBay Pharmaceuticals, Inc. Logo

NovaBay Pharmaceuticals, Inc.

Develops and commercializes eyecare, skincare, and wound care products.

NBY | US

Overview

Corporate Details

ISIN(s):
US66987P2011
LEI:
Country:
United States of America
Address:
2000 POWELL STREET, SUITE 1150, 94608 EMERYVILLE

Description

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company that develops and commercializes scientifically-created and clinically-proven products for the eyecare, skincare, and wound care markets. The company's core technology is a proprietary, stable formulation of hypochlorous acid. Its leading product is Avenova®, an antimicrobial lid and lash solution available over-the-counter for eye hygiene. In the wound care sector, NovaBay manufactures and sells products under the NeutroPhase® and PhaseOne® brands, which utilize its hypochlorous acid technology to aid in cleansing and debridement. The company focuses on providing accessible, problem-solving solutions for improved well-being.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all NovaBay Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NovaBay Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NovaBay Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

GC CELL CORPORATION Logo
Cell and gene therapy specialist with integrated CDMO, bio-logistics, and cell banking.
South Korea
144510
Gelteq Ltd Logo
Develops and manufactures a gel-based oral delivery system for drugs and nutrients.
United States of America
GELS
GemVax & KAEL Co.,Ltd. Logo
Clinical-stage biopharma developing therapeutics for neurodegenerative diseases.
South Korea
082270
Gencurix Inc. Logo
Develops and commercializes diagnostic solutions for precision medicine in oncology.
South Korea
229000
GENEDRIVE PLC Logo
Develops rapid, point-of-care pharmacogenetic testing platforms for personalized medicine.
United Kingdom
GDR
GENELUX Corp Logo
Clinical-stage biopharma developing oncolytic viral immunotherapies for solid tumors.
United States of America
GNLX
GENEMATRIX INC. Logo
Develops multiplex PCR diagnostic products for infectious diseases.
South Korea
109820
Generation Bio Co. Logo
Develops siRNA therapeutics delivered via ctLNPs for T cell-driven autoimmune diseases.
United States of America
GBIO
Clinical-stage biotech developing long-acting therapeutics for oncology and rare diseases.
South Korea
095700
Genfit S.A. Logo
Biopharmaceutical firm developing therapies and diagnostics for liver diseases.
United States of America
GNFT

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.